Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate R‐[¹¹C]verapamil

E-ISSN： 1528-1167|48|9|1774-1784

ISSN： 0013-9580

Source： EPILEPSIA, Vol.48, Iss.9, 2007-09, pp. : 1774-1784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human intestinal P-glycoprotein activity estimated by the model substrate digoxin

By Larsen U. L. Olesen Hyldahl Nyvold Guldborg Eriksen J. Jakobsen P. Østergaard M. Autrup H. Andersen V.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 2, 2007-01 ,pp. : 123-134

Informa Healthcare

Access to resources Recommend Favorite

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 202-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

¹¹C‐PE2I and ¹⁸F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

MOVEMENT DISORDERS, Vol. 33, Iss. 1, 2018-01 ,pp. : 117-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 11, 2015-11 ,pp. : 1105-1113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 885-6230, Iss. 11, 2015-11 ,pp. : 1105-1113

John Wiley & Sons Inc

Access to resources Recommend Favorite